AMELIE (Anchored Muscle cELls for IncontinencE) is a 5-year collaborative research project funded by the European Union Framework Programme (Horizon 2020). It involves the collaboration of 13 organisations across nine countries to develop and carry out research. The project will be co-ordinated by UCL and led by Richard Day, Professor of Regenerative Medicine Technology at UCL.
The consortium proposes a novel regenerative intervention using autologous skeletal muscle derived cells (ASMDC) to restore the function of the sphincter muscle. Scientists will attach ASMDC to implantable microcarriers to improve cell delivery and engraftment in patients with faecal incontinence. This will be tested in a randomised clinical trial. The strategy is expected to improve cell viability and increase the likelihood of muscle regeneration, contributing to improved continence.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874807.
Company Details
- Employees
- 14
- Address
- London, Gb
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://amelie-project.eu/
- HQ
- London
Amelie Questions
Amelie's website is https://amelie-project.eu/
Amelie's LinkedIn profile is https://uk.linkedin.com/company/amelieproject
Amelie has
14 employees.
View email and phone details for 14
employees at Amelie.
Amelie's industry is
Research Services
Amelie's top competitors are
Screen Hispania,
World Federation Of Incontinence And Pelvic Problems - Wfipp,
Chuckling Goat,
Pain Uk,
Bowel Research Uk,
Association For Continence Professionals,
The British Association Of Urological Surgeons,
W Automotive Consulting, S.l.,
Pain Concern,
Stahl Automotive Consulting.
Amelie's categories are Research Services
